INSIGHTS ON DRUG DEVELOPMENT

  • Technical Considerations For Developing Oral Solids (Part 2)

    What technical considerations should be at the forefront for your oral solids project? This two-part series features four oral solids experts from Pfizer CentreOne’s global network and partner organizations discussing the technical considerations to be aware of. In the second installment of the series, our experts consider the effects of equipment design and different tablet strategies.

  • Technical Considerations For Developing Oral Solids (Part 1)

    Navigating your oral solids project from development through commercial manufacture can be a challenging path. In a two-part series, four oral solids experts from Pfizer CentreOne’s global network and partner organizations discuss the technical considerations to be aware of. In this first installment, we look at the importance of technical groundwork and understanding excipients in the early stages of your project.

  • Enhanced Host Cell Protein Analysis In Biologics Manufacturing

    iEnzyme-Linked Immunosorbent Assays (ELISAs) to monitor host cell protein levels are challenging. This article illustrates an enhanced anti-host cell protein antibody coverage analysis method solution.

  • Expanding SPR Uses In Antibody Effector Function Determination

    To minimize risk and to get “true” affinity in binding analysis, we've adopted the latest innovation in surface plasmon resonance technology to develop and qualify assays for mAbs and other therapeutic proteins.

DRUG DEVELOPMENT SOLUTIONS

  • Microcentrifuge

    NuAire offers ventilated and refrigerated micro-centrifuges ideal for high and low speed applications for small sample volumes.

  • Formulation Development

    Bora formulation development team provides formulation development and solution from an early stage of new chemical entities (NCE) to generic products.

  • Integrated Biotech Services: From Strain To Commercial Product

    Backed by Lonza’s more than 30 years’ expe­rience and expertise in biological processing and our track record in the chemical and bio­technological industry, we offer our customers a full “one-stop-shop” service package at all stages of development and production.

  • PCI General Brochure

    PCI is an integrated full service provider and a trusted partner to leading companies in the global healthcare industry; we offer unparalleled expertise and experience in taking compounds from the earliest stages of development through to commercial launch, delivering speed to market and commercial success for our customers. Core services include: Analytical services, formulation development, clinical trial supply, commercial manufacturing and packaging, QP services, supply chain management, storage and distribution.

  • Jet Feeder System for Powder Feeding and Mixing

    The Jet Feeder is a multi purpose system for feeding powders into liquid and for low shear mixing. It is the perfect unit to use on those products that are sensitive to shear. ILC Dover completed a successful test at a pharmaceutical facility for mixing starch into solution for a tableting process. The system is cGMP, easy to clean or CIP, and will work in single pass processes or recirculating processes. JetSolutions is an ILC Dover company and is the manufacturer of the Jet Feeder.